Lillys Easy-to Use Once-Weekly GLP-1 Agonist Trulicity Approved in Europe Twitter Summary: Lillys Trulicity, a once-weekly GLP-1 agonist available in US, has now been approved in Europe On November 25, Eli Lillys Trulicity (dulaglutide) was approved in Europe for type 2 diabetes
If confirmed in larger prospective trials, these widely used drugs could offer a new potential approach to breast cancer prevention, especially for women with excess body weight
About half the size of the Hawaiian isles, or a bit smaller than Cyprus, the island has a diversity of elevations, climates and soils that lead to a range of vineyard terroir
The SURMOUNT-5 trial demonstrated an average 20.2% body weight reduction over 72 weeks
Strength training supports mental health too Many people start GLP-1 medication to address physical health concerns, but they often stick with their new habits because of how it makes them feel not just physically, but mentally